SABBY MANAGEMENT, LLC - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is and the CUSIP is 36197T903. A total of 5 filers reported holding GW PHARMACEUTICALS PLC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2017$12,989,000
+396.7%
1,074
+359.0%
0.70%
+361.2%
Q4 2016$2,615,000
-27.8%
234
-14.3%
0.15%
+11.8%
Q3 2016$3,624,000
+130.1%
273
+58.7%
0.14%
+65.9%
Q2 2016$1,575,000
+126.9%
172
+72.0%
0.08%
+115.8%
Q4 2015$694,000
-24.1%
1000.0%0.04%0.0%
Q3 2015$914,000
-50.4%
100
-33.3%
0.04%
-43.3%
Q2 2015$1,843,000
+102.3%
150
+50.0%
0.07%
+76.3%
Q1 2015$911,000
-82.5%
100
-79.4%
0.04%
-83.0%
Q2 2014$5,204,0004850.22%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 15,600$2,630,0000.03%
SIMPLEX TRADING, LLC 162$2,730,0000.01%
JPMORGAN CHASE & CO 55,000$9,271,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of GW PHARMACEUTICALS PLC shareholders